TP53 mutations are present in various human cancers (pancreatic adenocarcinoma, liver hepatocellular carcinoma, chromophobe renal cell carcinoma, acute myeloid leukemia, thymoma, etc.)and represent potential prognostic markers (37). The gene discussed is TP53; the disease is chromophobe renal cell carcinoma.